All In MedTech

Device Trial Radar · NCT07862283

Chitosan-Based, Gelatin Sponge and Non-absorbable Nasal Packing After Endoscopic Sinus Surgery

Chitosan-based Bioresorbable, Gelatin Sponge and Non-absorbable Polyvinyl Alcohol Nasal Packing After Endoscopic Sinus Surgery for Chronic Rhinosinusitis Without Nasal Polyps: a Prospective Comparative Study of Patient Comfort, Bleeding and Early Mucosal Healing

Last checked: Nov 19, 2026Latest source record: Oct 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

60

Actual

Start

Oct 15, 2024

Primary completion

Dec 25, 2025

Study completion Dec 30, 2025

Sponsor

Lead sponsor
Sakarya UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 7, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Sequential
Masking
Single (outcomes assessor)
Primary purpose
Supportive care
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This single-centre prospective study compared three nasal packing materials used after endoscopic sinus surgery (ESS) in adults with chronic rhinosinusitis without nasal polyps: a chitosan-based bioresorbable pack (PosiSep X), an absorbable gelatin sponge (Spongostan) and a non-absorbable polyvinyl alcohol (PVA) sinus pack. Sixty patients were allocated in three consecutive blocks of 20 by order of enrolment, with the order of materials determined by drawing lots (first 20 PosiSep X, next 20 Spongostan, last 20 PVA sinus pack); all materials were removed 48 hours after surgery. The study evaluated postoperative pain (visual analogue scale) with the pack in place and at removal, postoperative bleeding within the first 24 hours, nasal obstruction (NOSE score) on postoperative day 2 and at 1 month, and endoscopic adhesion and mucopurulent discharge scores at postoperative weeks 1 and 4.

Conditions

  • Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)

Interventions

  • PosiSep XDevice

    Chitosan (poly-D-glucosamine) bioresorbable nasal dressing, single application at the end of surgery

  • SpongostanDevice

    Absorbable gelatin sponge, single application at the end of surgery

  • Osseous polyvinyl alcohol sinus pack (EON Meditech)Device

    Non-absorbable polyvinyl alcohol sponge sinus pack with retrieval string (Osseous, EON Meditech Pvt. Ltd., Surat, India), single application at the end of surgery, removed at 48 hours

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Postoperative pain with the pack in situTime frame: 48 hours after surgery, before pack removal
  2. Pain at pack removalTime frame: At pack removal, 48 hours after surgery

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Sakarya University Training and Research Hospital

    Adapazarı, Sakarya, Turkey (Türkiye)

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.